Ignite Creation Date:
2025-12-24 @ 12:33 PM
Ignite Modification Date:
2026-02-20 @ 6:39 PM
Study NCT ID:
NCT03277261
Status:
COMPLETED
Last Update Posted:
2021-12-06
First Post:
2017-09-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 )
Sponsor:
TG Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-06
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-07
First Submit QC Date:
None
Study First Post Date:
2017-09-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-11-05
Results First Submit QC Date:
None
Results First Post Date:
2021-12-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-05-20
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-11-05
Last Update Post Date:
2021-12-06
Last Update Post Date Type:
ACTUAL